Proposal leaves surgeons bound by private health

23 February 2021 - Australians paying thousands of dollars a year in health insurance could have their access to life-changing ...

Read more →

Shionogi’s novel antibiotic, Fetcroja (cefiderocol), has been selected by UK’S NICE/NHSE&I as part of an antimicrobial subscription style reimbursement model

21 December 2020 - NICE and the National Health Service England and Improvement have recognised the potential of Shionogi’s innovative ...

Read more →

Diabetes drugs delay shows problem with PHARMAC’s funding model, doctor claims

14 December 2020 - Pharmac’s decision to delay funding approval for two new diabetes drugs has highlighted the shortcomings of ...

Read more →

PHARMAC to fund new haemophilia medicine

11 November 2020 - From 1 December 2020 a new medicine will be funded by PHARMAC which will help some people ...

Read more →

Update on proposal to fund two new medicines for type 2 diabetes mellitus

5 November 2020 - PHARMAC would like to thank everyone who provided feedback on a proposal to fund two new medicines, ...

Read more →

PHARMAC funding resources to focus on medicines access equity

3 November 2020 - PHARMAC is pleased to announce the launch of He Ako Hiringa, a clinical education provider with ...

Read more →

Budget is why PHARMAC is letting down New Zealanders, CEO says

22 October 2020 - PHARMAC is struggling to cater to the demand of Kiwis. ...

Read more →

Prime Minister committed to PHARMAC investigation, but Health Minister at odds

15 October 2020 - On 30 September Prime Minister Jacinda Ardern committed to having an investigation into PHARMAC’s decision-making processes, ...

Read more →

Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?

8 October 2020 - US drug prices are the highest in the world and are continuing to rise, with an increasing ...

Read more →

PHARMAC confirms their new way of contracting for medicines

7 October 2020 - PHARMAC is standardising the way medicines are contracted, providing better support to health care professionals when ...

Read more →

Landmark funding and long-term certainty for innovative medicines for Australian patients, the community and the economy

6 October 2020 - Medicines Australia welcomes the Federal Government’s landmark step to introduce a guaranteed PBS new medicines funding ...

Read more →

Improving access to medicines

6 October 2020 - The 2020-2021 Budget creates a landmark PBS New Medicines Funding Guarantee.  ...

Read more →

ACT would ensure an independent review of PHARMAC

30 September 2020 - “ACT will seek an independent review of PHARMAC’s operating model to allow for greater transparency and ...

Read more →

Labour's promised PHARMAC boost 'not enough'

30 September 2020 - Palmerston North cancer patient Lydia Pei looks likely to have to depend on the community, not ...

Read more →

Election campaign 2020: Jacinda Ardern unveils $1 billion health policy

29 September 2020 - Labour is promising to invest millions more in drug-buying agency PHARMAC and emergency dental care if ...

Read more →